Track topics on Twitter Track topics that are important to you
Canadian venture firm Quark Venture Inc. and Chinese investment bank GF Securities Co. Ltd. raised $100 million toward the planned $500 million Global Health Sciences Venture Fund. The Vancouver-based fund will invest globally in biotech and health sciences companies.
Earlier this month, the fund committed $30 million to MSI Methylation Sciences Inc. (Burnaby, B.C.), whose Strada (MS-195) is in Phase II testing to treat major depressive disorder (MDD).
Original Article: Quark, GF Securities raising $500M fundNEXT ARTICLE
Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...